167 related articles for article (PubMed ID: 36551562)
1. Long-Term Projections of Cancer Incidence and Mortality in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2054: An Empirical Validation Approach.
Nguyen PT; Saito E; Katanoda K
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551562
[TBL] [Abstract][Full Text] [Related]
2. Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study.
Nguyen PT; Hori M; Matsuda T; Katanoda K
Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1756-1770. PubMed ID: 37756571
[TBL] [Abstract][Full Text] [Related]
3. Short-term projection of cancer incidence in Japan using an age-period interaction model with spline smoothing.
Katanoda K; Kamo K; Saika K; Matsuda T; Shibata A; Matsuda A; Nishino Y; Hattori M; Soda M; Ioka A; Sobue T; Nishimoto H
Jpn J Clin Oncol; 2014 Jan; 44(1):36-41. PubMed ID: 24218520
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
5. Cost of illness in a super-aged society-comparison of breast, lung, and prostate cancer in Japan.
Matsumoto K; Hatakeyama Y; Seto K; Onishi R; Hirata K; Wu Y; Hasegawa T
BMC Geriatr; 2022 Dec; 22(1):964. PubMed ID: 36517755
[TBL] [Abstract][Full Text] [Related]
6. Projecting Cancer Incidence for 2025 in the 2 Largest Populated Cities in Vietnam.
Nguyen SM; Deppen S; Nguyen GH; Pham DX; Bui TD; Tran TV
Cancer Control; 2019; 26(1):1073274819865274. PubMed ID: 31331188
[TBL] [Abstract][Full Text] [Related]
7. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
[TBL] [Abstract][Full Text] [Related]
8. Burden of cancer and changing cancer spectrum among older adults in China: Trends and projections to 2030.
Shi Z; Lin J; Wu Y; Fu S; Wan Y; Fang Y
Cancer Epidemiol; 2022 Feb; 76():102068. PubMed ID: 34864577
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer.
Pak S; Jung KW; Park EH; Ko YH; Won YJ; Joung JY
Investig Clin Urol; 2022 Mar; 63(2):175-183. PubMed ID: 35244991
[TBL] [Abstract][Full Text] [Related]
11. Estimates and projections of value of life lost from cancer deaths in the United States.
Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
[TBL] [Abstract][Full Text] [Related]
12. Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
Xia C; Dong X; Li H; Cao M; Sun D; He S; Yang F; Yan X; Zhang S; Li N; Chen W
Chin Med J (Engl); 2022 Feb; 135(5):584-590. PubMed ID: 35143424
[TBL] [Abstract][Full Text] [Related]
13. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
14. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030.
Quante AS; Ming C; Rottmann M; Engel J; Boeck S; Heinemann V; Westphalen CB; Strauch K
Cancer Med; 2016 Sep; 5(9):2649-56. PubMed ID: 27356493
[TBL] [Abstract][Full Text] [Related]
15. Assessment of age, period, and cohort effects of lung cancer incidence in Hong Kong and projection up to 2030 based on changing demographics.
Du J; Sun H; Sun Y; Du J; Cao W; Sun S
Am J Cancer Res; 2021; 11(12):5902-5916. PubMed ID: 35018232
[TBL] [Abstract][Full Text] [Related]
16. Estimates of cancer burden in Lazio.
Rashid I; Pannozzo F; Rossi S; Foschi R
Tumori; 2013; 99(3):359-65. PubMed ID: 24158065
[TBL] [Abstract][Full Text] [Related]
17. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.
Bray F; Jemal A; Grey N; Ferlay J; Forman D
Lancet Oncol; 2012 Aug; 13(8):790-801. PubMed ID: 22658655
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence and mortality projections in the UK until 2035.
Smittenaar CR; Petersen KA; Stewart K; Moitt N
Br J Cancer; 2016 Oct; 115(9):1147-1155. PubMed ID: 27727232
[TBL] [Abstract][Full Text] [Related]
19. Estimates of cancer burden in Umbria.
Stracci F; Petrucci MS; Ciampichini R; Tavilla A; Foschi R
Tumori; 2013; 99(3):342-50. PubMed ID: 24158063
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
